Competition authority approves Meda's acquisition of Recip The Swedish Competition Authority has announced that nothing hinders Meda from acquiring Recip AB. The acquisition will be completed within short. For more information, please contact: Anders Larnholt, Investor Relations, tel.+46 709 458 878 MEDA AB (publ) is an international specialty pharma company that concentrates on marketing and market-adapted product development. Acquisitions and long-term partnerships are fundamental factors that drive the company's strategy. Meda is represented with own organisations in 26 countries and with more than 1 500 employees within marketing and sales. Meda's products are sold in approximately 120 countries world-wide. The Meda share is listed under Large Cap on the OMX Nordic Stock Exchange. Find out more, visit www.meda.se.
Competition authority approves Meda's acquisition of Recip
| Source: Meda AB